Polar Capital Biotechnology R USD
WKNA1W70F
AssetklasseAktien
54,802€+0,37€
27.02.2026 21:48+ 0,67%
54,802€+0,37€
27.02.2026 21:48+ 0,67%
Verkaufen
54,093VerkaufenStück: 200Kaufen
55,174KaufenStück: 200Eröffnung
53,826
Hoch
54,907
Tief
53,826
Umsatz
549,07
The objective of the Fund is to preserve capital and achieve longterm capital appreciation by investing worldwide in the shares of biotechnology, diagnostics and life sciences tools companies.The Fund is broadly diversified across countries, biotechnology sectors and by market-cap (a measure of company size).The Fund may invest in financial derivatives (complex instrumentsbased upon the value of underlying assets) for hedging, to reducerisk, to manage the Fund more efficiently, or to gain exposure tosecurities in a more efficient way.
Emittent
Fundrock Management Company (Ireland) Ltd
Benchmark
-
Fondsgröße in Mio.
2.828,937
Gesamtkostenquote (TER)
1,61 %
Tracking Difference
5,4281
Replikation
-
Fondswährung
USD
Domizil
IE
Fondsauflage
-
Ausschüttung
Ausschüttend
Ausschüttungsintervall
-
NAV
64,14
NAV Datum
26.2.2026